decisionhealth Newsletters, Answer Books - 2008 Issue 12 (December)
Physician_Fee_Schedule_Rules / 151-200
Subscribe or sign in to view the full article.
Article Overview
This Find-A-Code article covers Medicare End-Stage Renal Disease (ESRD) payment policy material within the physician fee schedule rules. It focuses on estimated drug spending, dialysis treatment volume, budget neutrality for composite rate updates, and the development and revision of patient characteristic case-mix adjustments. The content is relevant to coding, reimbursement, and dialysis operations stakeholders who need to understand how the rule addresses ESRD facility payment methodology and related data considerations.
Why This Topic Matters
The article is useful for anyone tracking Medicare ESRD reimbursement policy because it explains the broader payment framework, the data sources and assumptions used in rate-setting, and the policy areas that influence facility-level payment updates.
Article Sections
-
III. Dialysis Treatments
This section addresses dialysis treatment volume projections and the general basis for estimating total treatment counts for the payment period.
-
IV. Estimated Drug Spending
This section discusses aggregate drug spending estimates for ESRD-related therapies and the assumptions used to update spending projections.
-
V. Add-On Calculation and Budget Neutrality
This section covers the calculation framework used to compare projected payment amounts with prior system estimates and the resulting budget neutrality analysis.
-
A. Patient Characteristic Adjustments
This section describes the development and review of patient characteristic case-mix adjustments, including data sources, facility sampling issues, and related commentary.
-
1. Sample Data Used to Develop the Basic Case-Mix System
This subsection reviews the dataset used to build the case-mix methodology and the comments received about sample composition and timing.
-
2. Including Co-morbid Conditions in the Case-mix Adjustment
This subsection addresses comments on co-morbid condition reporting and the role of those conditions in the case-mix framework.
What You Will Learn
- How the article frames ESRD dialysis treatment projections in relation to Medicare payment policy
- What categories of drug spending updates are discussed for ESRD facilities
- How the article approaches budget neutrality for ESRD payment updates
- What types of patient characteristics and data issues are addressed in the case-mix adjustment discussion
- How the rule responds to comments about sample selection, data availability, and co-morbid condition reporting
Who Should Read This
- Medical coders
- Revenue cycle professionals
- Dialysis facility administrators
- Compliance staff
- Healthcare reimbursement analysts
- Medicare payment policy researchers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com